Effects of lipopolysaccharide on intestinal P-glycoprotein expression and activity

European Journal of Pharmacology

Volumn 565, Issue 1-3, 2007, Pages 220-224

  Moriguchi, Jun ^a   Kato, Ryuji ^a   Nakagawa, Machiko ^a   Hirotani, Yoshihiko ^b   Ijiri, Yoshio ^a   Tanaka, Kazuhiko ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Department of Clinical Pharmacy and Clinical Pharmacokinetics   (Japan)

Author keywords

FD 4; Intestine; Lipopolysaccharide; P glycoprotein; Rhodamine 123

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GLYCOPROTEIN P; LIPOPOLYSACCHARIDE; RHODAMINE 123;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SEPSIS; SMALL INTESTINE; WESTERN BLOTTING; WISTAR RAT;

ANIMALS; FORKHEAD TRANSCRIPTION FACTORS; INTESTINES; LIPOPOLYSACCHARIDES; MALE; P-GLYCOPROTEIN; PERMEABILITY; RATS; RATS, WISTAR; RHODAMINE 123; XENOPUS PROTEINS;

EID: 34249044811     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.02.058     Document Type: Article

References (17)

1. Ando H., Nishio Y., Ito K., Nakao A., Wang L., Zhao Y.L., Kitaichi K., Takagi K., and Hasegawa T. Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats. Antimicrob. Agents. Chemother 45 (2001) 3462-3467
2. Belpaire F.M., Smet F.D., Chindavijak B., Fraeyman N., and Bogaert M.G. Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat. Fundam. Clin. Pharmacol. 3 (1989) 79-88
3. Buyse M., Radeva G., Bado A., and Farinotti R. Intestinal inflammation induces adaption of P-glycoprotein expression and activity. Biochem. Pharmacol. 69 (2005) 1745-1754
4. Funakoshi S., Murakami T., Yumoto R., Kiribayashi Y., and Takano M. Role of P-glycoprotein in pharmacokinetics and drug interactions of digoxin and β-methyldigoxin in rats. J. Pharmacol. Sci. 92 (2003) 1455-1463
5. Kalitsky-Szirtes J., Shayeganpour A., Brocks D.R., and Piquette-Miller M. Surpression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats. Drug. Metab. Dispos. 32 (2004) 20-27
6. Kawahara M., Sakata A., Miyashita T., Tamai I., and Tsuji A. Physiologically Based Pharmacokinetics of digoxin in mdra1a knockout mice. J. Pharm. Sci. 88 (1999) 1281-1287
7. Mayer U., Wagenaar E., Beijinen J.H., Smith J.W., Meijer D.K., van Asperen J., Borst P., and Schinkel A.H. Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein. Br. J. Pharmacol. 119 (1996) 1038-1044
8. Miyoshi M., Nadai M., Nitta A., Ueyama J., Shimizu A., Takagi K., Nabeshima T., Takagi K., Saito K., and Hasegawa T. Role of tumor necrosis factor-α in down-regulation of hepatic cytochrome P450 and P-glycoprotein by endotoxin. Eur. J. Pharmacol. 507 (2005) 229-237
9. Nishihori T., Fujiwara A., Amano F., Hirotani Y., and Tanaka K. Effect of lipopolysaccharide on the pharmacokinetics of digoxin in rats. J. Endotoxin. Res. 10 (2004) (Abstracts of 8th IES)
10. Ohkubo R., Tomita M., Hotta Y., Nagira M., and Hyashi M. Comparative study of flux of FITC-labeled dextran 4000 on normal (iso)-and hyper-osmolarity in basal side in Caco-2 cell monolayers. Drug Metab. Pharmacokinet. 18 (2003) 404-408
11. Piquette-Miller M., Pak A., Kim H., Anari R., and Shahzamani A. Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation. Pharm. Res. 15 (1998) 706-711
12. Russell D.H., Barreto J.C., Klemm K., and Miller T.A. Hemorrhagic shock increases gut macromolecular permeability in the rat. Shock 4 (1995) 50-55
13. Salzman A.L., Wang H., Wollert P.S., VanderMeer T.J., Compton C.C., Denenberg A.G., and Fink M.P. Endotoxin-induced ileal mucosal hyperpermeability in pigs: role of tissue acidosis. Am. J. Physiol. 266 (1994) G633-G646
14. Tang W., Yi C., Kalitsky J., and Piquette-Miller M. Endotoxin downregulates hepatic expression of P-glycoprotein and MRP2 in 2-acetylaminofluorene-treated rats. Mol. Cell. Biol. Res. Commun. 4 (2000) 90-97
15. Trauner M., Arrese M., Soroka C.J., Ananthanarayanan M., Koeppel T.A., Schlosser S.F., Suchy F.J., Keppler D., and Boyer J.L. The rat canalicular conjugate export pump (Mrp2) is downregulated in intrahepatic and obstructive cholestasis. Gastroenterology 113 (1997) 255-264
16. Tsuji A., and Tamai I. Carried-mediated intestinal transport of drugs. Pharm. Res. 13 (1996) 963-977
17. Yumoto R., Murakami T., Nakamoto Y., Hasegawa R., Nagai J., and Takano M. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytocrome P-450 3A-related compounds. J. Pharmacol. Exp. Ther. 289 (1999) 149-155